Ureteroscopy 

  • Author: Michael Grasso III, MD; Chief Editor: Bradley Fields Schwartz, DO, FACS   more...
 
Updated: Jan 19, 2012
 

Background

Ureteroscopy is defined as upper urinary tract endoscopy performed most commonly with an endoscope passed through the urethra, bladder, and then directly into the upper urinary tract. Indications for ureteroscopy have broadened from diagnostic endoscopy to various minimally invasive therapies.

See image below.

Flexible fiberoptic ureteropyeloscope. Flexible fiberoptic ureteropyeloscope.

Endoscopic lithotripsy, treatment of upper urinary tract urothelial malignancies, stricture incisions, and ureteropelvic junction obstruction repair are all current treatments facilitated by contemporary ureteroscopic techniques. Because the application of ureteroscopic procedures has evolved from a diagnostic tool to a facilitator in complex therapeutic interventions, a proportional increase in the rate and severity of complications would be expected. However, with improved instrumentation and evolution of surgical technique, the complication rate associated with ureteropyeloscopy has actually decreased significantly.

Next

History of the Procedure

The progression from cystoscopy to upper urinary tract endoscopy was natural, with pediatric cystoscopes being used as the first rigid rod-lens ureteroscopes. Relatively large rod-lens endoscopes, averaging 12F (3F = 1 mm) in diameter, combined with ultrasonic and electrohydraulic lithotripsy probes became the first commonly accepted ureteroscopic equipment combination used to treat distal ureteral calculi.

Ureteroscopic treatment of calculi and, in particular, distal ureteral stones was the first common application of upper urinary tract endoscopy. Early in this evolution, smaller and more precise instrumentation was obviously found to cause less trauma to normal tissues. Rigid ureteroscopes progressed from rod-lens imaging to fiberoptic imaging with outer-diameter miniaturization. The narrow and delicate distal ureter once required vigorous balloon dilation for ureteroscopic access; however, by 1989, the fiberoptic-based rigid endoscopes were small enough (averaging 7F in diameter) for frequent placement in the distal ureter under direct vision. The small rigid ureteroscopes combined with both laser and pneumatic lithotriptors are currently used to treat distal ureteral calculi in both university and community settings.

Flexible ureteroscopy was an attractive alternative to rigid ureteroscopy in that the more proximal ureter and intrarenal collecting system was theoretically more easily accessible with this type of instrument. The application of flexible ureteroscopy was first reported by Marshall in 1964.[1] A 9F fiberscope manufactured by American Cystoscope Makers (Pelham Manor, NY) was passed into the ureter to visualize an impacted ureteral calculus. These first flexible ureteroscopes were not capable of being directed and did not have a working channel, thus permitting only the most primitive diagnostic maneuvers. The subsequent addition of a cystoscopically placed guide tube facilitated placement of the first flexible ureteroscopes. In addition, irrigant then could be passed through the guide tube to displace the ureteral mucosa and debris from the distal endoscopic lens.

In the early 1980s, Bagley, Huffman, and Lyon began work at the University of Chicago to develop an improved flexible fiberoptic ureteropyeloscope.[2] Three major design changes improved the potential of the flexible ureteroscope. First, the addition of a working channel allowed irrigant and endoscopic accessories to be passed directly through the endoscope rather than through an operating sheath. Second, active tip deflection allowed the endoscope to be directed or steered to areas of interest. Finally, by altering the stiffness (ie, based on durometer measurements) of the endoscope shaft, the actively deflecting portion could be combined with passive buckling of the endoscope (ie, secondary deflection), which facilitated lower-pole intrarenal access as depicted below.

Secondary endoscope deflection that allows lower-pSecondary endoscope deflection that allows lower-pole intrarenal access.

The first steerable, actively deflectable, flexible ureteropyeloscopes were equipped with relatively large fiberoptic bundles for imaging and illumination. The addition of the working channel and a cable-and-pulley system used for active tip deflection required on outer diameter of 3.6 mm. By the late 1980s, optical fiber miniaturization and improved geometrical pixel packing produced a smaller fiberoptic bundle and thus, a smaller-diameter endoscope. Flexible ureteroscope specifications in 1990 included a 10F outer diameter, a standard 3.6F working channel, and unidirectional active tip deflection. Working sheaths were abandoned for direct guidewire endoscope placement, but intramural ureteral dilation was often required for placement of the flexible ureteroscope into the upper urinary tract. These endoscopes were used to inspect the entire intrarenal collecting system and became part of the standard evaluation of filling defects of the upper urinary tract defined using contrast imaging studies.

The introduction of a new generation of flexible ureteroscopes, which offer greater active deflection, has significantly advanced the therapeutic and diagnostic efficacy of the flexible ureteroscope, allowing for greater access to all aspects of the upper urinary tract.

Currently, rigid and flexible ureteroscopes average 7.5F in tip diameter and are passed atraumatically into the upper urinary tract without intramural dilation. These endoscopes are used to treat various upper urinary tract disorders, including stones, urothelial malignancies, stricture disease, and bleeding lesions. The addition of laser energy applied through optical quartz fibers passed through the working channel of the endoscope has facilitated these treatments. Specific treatments are discussed further in subsequent sections of this article.

Previous
Next

Problem

Ureteroscopy is used as a diagnostic tool in situations such as investigating abnormal imaging findings, assessing obstruction or unilateral essential hematuria, or localizing the source of positive urinary cytology results.

Therapeutic uses of ureteroscopy have broadened to include various minimally invasive therapies. Endoscopic lithotripsy (treating stones), treatment of upper urinary tract urothelial malignancies, stricture incisions, and ureteropelvic junction obstruction repair are all current treatments facilitated by contemporary ureteroscopic techniques.

Previous
Next

Epidemiology

Frequency

Ureteroscopy is a routine procedure performed by urologists. The most common indication is to treat upper urinary tract calculi, particularly those that are either unsuitable for extracorporeal shockwave lithotripsy or are refractory to that form of treatment. Other common indications include evaluation of an abnormal lesion revealed by less invasive imaging tools (eg, intravenous pyelography [IVP], MRI, CT scanning) or localization of the source of positive urine culture or cytology results. Thus, ureteroscopy is often an essential part of the diagnostic algorithm and can also be used to treat the underlying disorder.

Previous
Next

Indications

Diagnostic indications for ureteropyeloscopy are as follows:

  • Abnormal imaging findings - Filling defect
  • Obstruction - Determination of etiology
  • Unilateral essential hematuria
  • Localizing source of positive urinary cytology results, culture results, or other test results
  • Evaluation of ureteral injury

Therapeutic indications for ureteropyeloscopy are as follows:

  • Endoscopic lithotripsy
  • Retrograde endopyelotomy
  • Incision of ureteral strictures
  • Improvement of calyceal drainage
  • Treatment of calyceal diverticular lesions
  • Treatment of malignant urothelial tumors
  • Treatment of benign tumors and bleeding lesions
Previous
Next

Relevant Anatomy

The ureter has 3 physiologic narrowings: (1) the ureteropelvic junction, (2) the crossing over the iliac vessels, and (3) the ureterovesical junction. This is crucial in the manifestations of calculus disease. These narrowings may result in ureteral stones becoming trapped and obstructing at these specific levels. For more information about the relevant anatomy, see Ureter Anatomy.

The segments of the ureter in which calculi can become lodged are also natural barriers for the ureteroscope. The intramural ureter is the narrowest segment and can prohibit endoscope passage. Guidewires are often passed into the ureteral orifice cystoscopically and are then directed into the renal pelvis with fluoroscopic assistance. These safety guidewires straighten the ureter and facilitate (1) the dilation of obstructed segments with balloon or graduated dilators and (2) the placement of internal stents used after many therapeutic procedures.

The intramural ureter once required balloon dilation for endoscope access. Currently, the small-diameter semirigid ureteroscopes are often narrower than 7.5F in tip diameter, while their shaft is straight or graduated. This allows for tip access, and, when advanced, the intramural segment may also be modestly dilated (ie, dilation under direct vision). Use of a dilator or sheath to facilitate passage of the ureteroscope beyond the intramural ureter is recommended when repeated access to the ureter is expected or if the intramural ureter is unusually tight or restrictive. Otherwise, the use of such sheaths is optional and generally not required.

As the fiberoptic-based rigid ureteroscope continues proximally past the ureteral orifice, it then is inhibited by the natural curvature of the ureter as it crosses the iliac vessels, psoas muscle, and the ureteropelvic junction. If the ureter is dilated, the rigid endoscope may be safely passed proximally. If not, then conversion to an actively deflectable flexible endoscope is indicated.

Flexible ureteroscopes are passed into the upper urinary tract over a guidewire with a wireless technique. Some authors have espoused the use of a 12F or 14F operating sheath to facilitate placement of this instrument. In a recent study of 1000 consecutive flexible ureteroscopic procedures using 7.5F instruments, this was not required. The flexible ureteroscope is a particularly useful instrument, especially when a rigid endoscope cannot be placed safely into the more proximal ureter or if intrarenal inspection is required. In these cases, active and passive endoscope tip deflection is essential to completely inspect the calyces.

Lower-pole intrarenal access performed with a flexible ureteroscope is often difficult and requires both active and passive flexible ureteroscope deflections. To place the tip of the endoscope into the lower pole, the instrument must first be actively deflected and then advanced to allow the shaft below to buckle as depicted below. This maneuver, termed secondary deflection, is required in 60% of traditional flexible ureteroscopies for a complete inspection. The increased active deflection offered by new-generation flexible ureteroscopes significantly decreases the need for secondary deflection and enhances the surgeon’s ability to inspect all aspects of the renal collecting system.

The instillation of radiopaque contrast material tThe instillation of radiopaque contrast material through the working channel of the flexible ureteroscope defines the lower-pole location of the tip of the endoscope.
Previous
Next

Contraindications

Diagnostic ureteroscopy has few contraindications. Untreated urinary tract infection, endoscopy without appropriate antibiotic coverage, and uncorrected bleeding diathesis are relative contraindications.

Contraindications to therapeutic ureteroscopy (eg, lithotripsy, endopyelotomy, tumor therapy) are more numerous and can mirror those associated with the corresponding more invasive open surgical intervention. In general, the major contraindications are related to untreated infections and uncorrected bleeding diathesis prior to therapeutic endoscopy.

Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Michael Grasso III, MD  Director of Endourology, Lenox Hill Hospital; Professor and Vice Chairman, Department of Urology, New York Medical College

Michael Grasso III, MD is a member of the following medical societies: American Medical Association, American Urological Association, Endourological Society, Medical Society of the State of New York, National Kidney Foundation, Société Internationale d'Urologie (International Society of Urology), and Society of Laparoendoscopic Surgeons

Disclosure: Karl Storz Endoscopy Consulting fee Consulting; Boston Scientific Consulting fee Consulting; Cook Urologic Consulting fee Consulting

Coauthor(s)

Paul Pyo, MD  Staff Physician, Department of Urology, New York Medical College

Disclosure: Nothing to disclose.

G Blake Johnson, MD  Consulting Staff, Middleton Urology Associates

G Blake Johnson, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, and American Urological Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Daniel B Rukstalis, MD  Director of Urological Services, Geisinger Medical Center, Geisinger Medical Group

Daniel B Rukstalis, MD is a member of the following medical societies: American Association for the Advancement of Science and American Urological Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Dan Theodorescu, MD, PhD  Paul A Bunn Professor of Cancer Research, Professor of Surgery and Pharmacology, Director, University of Colorado Comprehensive Cancer Center

Dan Theodorescu, MD, PhD is a member of the following medical societies: American Cancer Society, American College of Surgeons, American Urological Association, Medical Society of Virginia, Society for Basic Urologic Research, and Society of Urologic Oncology

Disclosure: Key Genomics Ownership interest Co-Founder-50% Stock Ownership; KromaTiD, Inc Stock Options Board membership

J Stuart Wolf Jr, MD, FACS  The David A Bloom Professor of Urology, Director, Division of Endourology and Stone Disease, Department of Urology, University of Michigan Medical School

J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology

Disclosure: Nothing to disclose.

Chief Editor

Bradley Fields Schwartz, DO, FACS  Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists

Disclosure: Nothing to disclose.

Additional Contributors

Medscape Reference thanks Dennis G Lusaya, MD, Associate Professor II, Department of Surgery (Urology), University of Santo Tomas; Head of Urology Unit, Benavides Cancer Institute, University of Santo Tomas Hospital; Chief of Urologic Oncology, St Luke’s Medical Center Global City, Philippines, for the video contribution to this article.

Medscape Reference also thanks Edgar V Lerma, MD, FACP, FASN, FAHA, Clinical Associate Professor of Medicine, Section of Nephrology, Department of Medicine, University of Illinois at Chicago College of Medicine; Research Director, Internal Medicine Training Program, Advocate Christ Medical Center; Consulting Staff, Associates in Nephrology, SC, for his assistance with the video contribution to this article.

References
  1. Marshall VF. Fiber Optics in Urology. J Urol. Jan 1964;91:110-4. [Medline].

  2. Bagley DH, Huffman JL, Lyon ES. Combined rigid and flexible ureteropyeloscopy. J Urol. Aug 1983;130(2):243-4. [Medline].

  3. Johnson GB, Portela D, Grasso M. Advanced ureteroscopy: wireless and sheathless. J Endourol. Aug 2006;20(8):552-5. [Medline].

  4. Aboumarzouk OM, Kata SG, Keeley FX, Nabi G. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. Dec 7 2011;12:CD006029. [Medline].

  5. Chen GL, Bagley DH. Ureteroscopic surgery for upper tract transitional-cell carcinoma: complications and management. J Endourol. May 2001;15(4):399-404; discussion 409. [Medline].

  6. Lee D, Trabulsi E, McGinnis D, Strup S, Gomella LG, Bagley D. Totally endoscopic management of upper tract transitional-cell carcinoma. J Endourol. Feb 2002;16(1):37-41. [Medline].

  7. Blute ML, Segura JW, Patterson DE. Ureteroscopy. J Urol. Mar 1988;139(3):510-2. [Medline].

  8. Grasso M, Bagley D. Small diameter, actively deflectable, flexible ureteropyeloscopy. J Urol. Nov 1998;160(5):1648-53; discussion 1653-4. [Medline].

  9. Abdel-Razzak OM, Bagley DH. Clinical experience with flexible ureteropyeloscopy. J Urol. Dec 1992;148(6):1788-92. [Medline].

  10. Harmon WJ, Sershon PD, Blute ML, Patterson DE, Segura JW. Ureteroscopy: current practice and long-term complications. J Urol. Jan 1997;157(1):28-32. [Medline].

  11. Bagley D. Active versus passive deflection in flexible ureteroscopy. J Endourol. 1987;1:15.

  12. Bagley DH. Intrarenal access with the flexible ureteropyeloscope: effects of active and passive tip deflection. J Endourol. Jun 1993;7(3):221-4. [Medline].

  13. Bagley DH. Removal of upper urinary tract calculi with flexible ureteropyeloscopy. Urology. May 1990;35(5):412-6. [Medline].

  14. Bagley DH. Ureteral endoscopy with passively deflectable, irrigating flexible ureteroscopes. Urology. Feb 1987;29(2):170-3. [Medline].

  15. Bagley DH, Allen J. Flexible ureteropyeloscopy in the diagnosis of benign essential hematuria. J Urol. Mar 1990;143(3):549-53. [Medline].

  16. Bagley DH, Huffman JL, Lyon ES. Flexible ureteropyeloscopy: diagnosis and treatment in the upper urinary tract. J Urol. Aug 1987;138(2):280-5. [Medline].

  17. Bagley DH, Liu JB, Goldberg BB, Grasso M. Endopyelotomy: importance of crossing vessels demonstrated by endoluminal ultrasonography. J Endourol. Dec 1995;9(6):465-7. [Medline].

  18. Bagley DH, Rivas D. Upper urinary tract filling defects: flexible ureteroscopic diagnosis. J Urol. Jun 1990;143(6):1196-200. [Medline].

  19. Berci G. Instrumentation: flexible fiber endoscopes. In: Berci G, ed. Endoscopy. New York, NY: Appleton-Century-Crofts; 1976.

  20. Bierkens AF, Hendrikx AJ, De La Rosette JJ, Stultiens GN, Beerlage HP, Arends AJ, et al. Treatment of mid- and lower ureteric calculi: extracorporeal shock-wave lithotripsy vs laser ureteroscopy. A comparison of costs, morbidity and effectiveness. Br J Urol. Jan 1998;81(1):31-5. [Medline].

  21. Conlin M, Bagley DH. Incisional treatment of ureteral strictures. In: Smith AD, Lingeman JE, Bagley DH, Preminger GM, Clayman RV, Badlani GH, Jordan GH, Kavoussi LV, Segura JW, eds. Smith's Textbook of Endourology. Vol 1. St Louis, Mo: Quality Medical Publishing; 1996:497-505.

  22. Conlin MJ, Bagley DH. Ureteroscopic endopyelotomy at a single setting. J Urol. Mar 1998;159(3):727-31. [Medline].

  23. Denstedt JD, Clayman RV. Electrohydraulic lithotripsy of renal and ureteral calculi. J Urol. Jan 1990;143(1):13-7. [Medline].

  24. Elbahnasy AM, Shalhav AL, Hoenig DM, Elashry OM, Smith DS, McDougall EM, et al. Lower caliceal stone clearance after shock wave lithotripsy or ureteroscopy: the impact of lower pole radiographic anatomy. J Urol. Mar 1998;159(3):676-82. [Medline].

  25. Erhard M, Salwen J, Bagley DH. Ureteroscopic removal of mid and proximal ureteral calculi. J Urol. Jan 1996;155(1):38-42. [Medline].

  26. Fabrizio MD, Behari A, Bagley DH. Ureteroscopic management of intrarenal calculi. J Urol. Apr 1998;159(4):1139-43. [Medline].

  27. Goodman TM. Ureteroscopy with pediatric cystoscope in adults. Urology. Apr 1977;9(4):394. [Medline].

  28. Grasso M. Experience with the holmium laser as an endoscopic lithotrite. Urology. Aug 1996;48(2):199-206. [Medline].

  29. Grasso M. Resecting upper-tract urothelial Ca by ureteroscopy. Contemp Urol. Dec 1993;5(12):52-9. [Medline].

  30. Grasso M. Flexible Fiberoptic Ureteropyeloscopy. In: Smith AD, Lingeman JE, Bagley DH, Preminger GM, Clayman RV, Badlani GH, Jordan GH, Kavoussi LV, Segura JW, eds. Smith's Textbook of Endourology. Vol 1. St Louis, Mo: Quality Medical Publishing; 1996:443-54.

  31. Grasso M. Ureteropyeloscopic treatment of ureteral and intrarenal calculi. Urol Clin North Am. Nov 2000;27(4):623-31. [Medline].

  32. Grasso M, Bagley D. A 7.5/8.2 F actively deflectable, flexible ureteroscope: a new device for both diagnostic and therapeutic upper urinary tract endoscopy. Urology. Apr 1994;43(4):435-41. [Medline].

  33. Grasso M, Bagley DH. Flexible ureteroscopic lithotripsy using pulsed-dye laser. J Endourol. 1990;4:155.

  34. Grasso M, Conlin M, Bagley D. Retrograde ureteropyeloscopic treatment of 2 cm. or greater upper urinary tract and minor Staghorn calculi. J Urol. Aug 1998;160(2):346-51. [Medline].

  35. Grasso M, Ficazzola M. Retrograde ureteropyeloscopy for lower pole caliceal calculi. J Urol. Dec 1999;162(6):1904-8. [Medline].

  36. Grasso M, Fraiman M, Levine M. Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies. Urology. Aug 1999;54(2):240-6. [Medline].

  37. Grasso M, Lang G, Loisides P, Bagley D, Taylor F. Endoscopic management of the symptomatic caliceal diverticular calculus. J Urol. Jun 1995;153(6):1878-81. [Medline].

  38. Grasso M, Liu JB, Goldberg B, Bagley DH. Submucosal calculi: endoscopic and intraluminal sonographic diagnosis and treatment options. J Urol. May 1995;153(5):1384-9. [Medline].

  39. Grasso M, Loisides P, Beaghler M, Bagley D. The case for primary endoscopic management of upper urinary tract calculi: I. A critical review of 121 extracorporeal shock-wave lithotripsy failures. Urology. Mar 1995;45(3):363-71. [Medline].

  40. Grotas A, Grasso M. Endoluminal sonographic imaging of upper urinary tract: three-dimensional reconstruction. J Endourol. Jun 2001;15(5):485-8. [Medline].

  41. Hudson RG, Conlin MJ, Bagley DH. Ureteric access with flexible ureteroscopes: effect of the size of the ureteroscope. BJU Int. May 2005;95(7):1043-4. [Medline].

  42. Johnson GB, Fraiman M, Grasso M. Broadening experience with the retrograde endoscopic management of upper urinary tract urothelial malignancies. BJU Int. Mar 2005;95 Suppl 2:110-3. [Medline].

  43. Johnson GB, Grasso M. Exaggerated primary endoscope deflection: initial clinical experience with prototype flexible ureteroscopes. BJU Int. Jan 2004;93(1):109-14. [Medline].

  44. Keeley FX Jr, Bibbo M, Bagley DH. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol. May 1997;157(5):1560-5. [Medline].

  45. Keeley FX, Kulp DA, Bibbo M, McCue PA, Bagley DH. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. Jan 1997;157(1):33-7. [Medline].

  46. Kumon H, Tsugawa M, Matsumura Y, Ohmori H. Endoscopic diagnosis and treatment of chronic unilateral hematuria of uncertain etiology. J Urol. Mar 1990;143(3):554-8. [Medline].

  47. Lam JS, Gupta M. Ureteroscopic management of upper tract transitional cell carcinoma. Urol Clin North Am. Feb 2004;31(1):115-28. [Medline].

  48. Liu JB, Bagley DH, Conlin MJ, Merton DA, Alexander AA, Goldberg BB. Endoluminal sonographic evaluation of ureteral and renal pelvic neoplasms. J Ultrasound Med. Aug 1997;16(8):515-21; quiz 523-4. [Medline].

  49. Lyon ES, Banno JJ, Schoenberg HW. Transurethral ureteroscopy in men using juvenile cystoscopy equipment. J Urol. Aug 1979;122(2):152-3. [Medline].

  50. McMurtry JM, Clayman RV, Preminger GM. Endourological diagnosis and treatment of essential hematuria. J Endourol. 1987;1:145.

  51. Preminger GM, Kennedy TJ. Ureteral stone extraction utilizing non-deflectable flexible fiberoptic ureteroscopes. J Endourol. 1987;1:31.

  52. Razdan S, Johannes J, Cox M, Bagley DH. Current practice patterns in urologic management of upper-tract transitional-cell carcinoma. J Endourol. Apr 2005;19(3):366-71. [Medline].

  53. Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, et al. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol. Jun 1994;151(6):1648-51. [Medline].

  54. Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, et al. Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol. Nov 1997;158(5):1915-21. [Medline].

  55. Soderdahl DW, Fabrizio MD, Rahman NU, Jarrett TW, Bagley DH. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol. Mar-Apr 2005;23(2):114-22. [Medline].

  56. Stoller ML, Wolf JS Jr, Hofmann R, Marc B. Ureteroscopy without routine balloon dilation: an outcome assessment. J Urol. May 1992;147(5):1238-42. [Medline].

  57. Streem SB, Pontes JE, Novick AC, Montie JE. Ureteropyeloscopy in the evaluation of upper tract filling defects. J Urol. Aug 1986;136(2):383-5. [Medline].

  58. Suh RS, Faerber GJ, Wolf JS Jr. Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. J Urol. Dec 2003;170(6 Pt 1):2209-16. [Medline].

  59. Takagi T, Go T, Takayasu H, Aso Y, Hioki R. Small-caliber fiberscope for visualization of the urinary tract, biliary tract, and spinal canal. Surgery. Dec 1968;64(6):1033-8. [Medline].

  60. Tawfiek ER, Liu JB, Bagley DH. Ureteroscopic treatment of ureteropelvic junction obstruction. J Urol. Nov 1998;160(5):1643-6; discussion 1646-7. [Medline].

  61. Teichman JM, Champion PC, Wollin TA, Denstedt JD. Holmium:YAG lithotripsy of uric acid calculi. J Urol. Dec 1998;160(6 Pt 1):2130-2. [Medline].

  62. Wollin TA, Teichman JM, Rogenes VJ, Razvi HA, Denstedt JD, Grasso M. Holmium:YAG lithotripsy in children. J Urol. Nov 1999;162(5):1717-20. [Medline].

Previous
Next
 
Flexible fiberoptic ureteropyeloscope.
Secondary endoscope deflection that allows lower-pole intrarenal access.
Plain radiograph that defines a large renal pelvic calculus with the flexible ureteroscope passed beyond the stone burden.
The instillation of radiopaque contrast material through the working channel of the flexible ureteroscope defines the lower-pole location of the tip of the endoscope.
Ureteroscopic image of an impacted jack stone in the ureter. These calculi are composed of calcium oxalate monohydrate.
Ureteroscopic image of a papillary transitional cell carcinoma of the ureter.
Ureteroscopy and laser lithotripsy. Video courtesy of Dennis G Lusaya, MD, and Edgar V Lerma, MD.
Table 1. Comparison of Complication Rates Associated With Ureteroscopy, Emphasizing the Noticeable Decrease in the Major Complication Rate With Greater Experience and Endoscope Miniaturization
AuthorBlute et al[7] Abdel-Razzak and Bagley[9] Harmon et al[10] Grasso and Bagley[8]
Year Published1988199219971998
Procedures346290209584
Minor Complications, %
Colic/pain---93.55.5
Fever6.26.921.4
False passage0.9------0.4
Hematuria
Minor



Prolonged



0.5



0.3



2.1



1



0



0



0.7



0.2



Extravasation0.61------
Urinary tract infection---1---1.6
Pyelonephritis---------0.5
Major Complications, %
Perforation4.61.710
Stricture1.40.70.50.5
Avulsion0.6000
Urinoma0.6---00
Urosepsis0.3000
Cardiovascular accident------0.50.2
Deep vein thrombosis---------0.2
Table 2. New York University Experience With Ureteroscopic Treatment of Ureteral Calculi Using the Holmium:YAG Laser
SegmentNumber of CasesMean Diameter,



mm (range, mm)



Success Rate,



First-Stage Treatment



and Second -Stage Treatment



Proximal third7511.3 (30-5)95% and 96%
Middle third4510.7 (60-5)98% and 100%
Distal third9110.3 (50-4)99% and 100%
Totals21197% and 99%
Table 3. New York University Experience With Ureteropyeloscopic Treatment of Intrarenal Calculi Using the Holmium:YAG Laser
LocationNumber of CasesMean Diameter,



mm (range, mm)



Success Rate, Treatment



and Multistage Treatment



Upper pole5810.6 (35-4)90% and 97%
Middle pole3011.1 (23-4)90% and 93%
Lower pole10314.8 (40-3)79% and 85%
Renal pelvic3720.5 (60-6)78% and 95%
Totals22881% and 90%
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.